financetom
Business
financetom
/
Business
/
Market Chatter: Icahn Enterprises Plans to Raise Stake in CVR Energy to Over 81%
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Icahn Enterprises Plans to Raise Stake in CVR Energy to Over 81%
Nov 9, 2024 12:55 PM

04:31 AM EST, 11/08/2024 (MT Newswires) -- Icahn Enterprises ( IEP ) plans to increase its stake in CVR Energy ( CVI ) to over 81% from 66%, The Wall Street Journal reported late Thursday, citing draft statements from Icahn.

Icahn Enterprises ( IEP ), which is controlled by activist investor Carl Icahn, plans to buy up to an additional 15 million shares of CVR at a price of $17.50 per share, according to the report.

The firm intends to fund the purchase and other potential transactions by cutting its quarterly dividend by half to $0.50 per share, WSJ reported.

"Rarely have I seen a stock market with such extreme valuations - with some companies trading at unjustifiable premiums and others being massively undervalued," Icahn was quoted as saying. "These undervalued situations have created great opportunities for activists."

Icahn Enterprises ( IEP ) and CVR Energy ( CVI ) did not immediately respond to MT Newswires' requests for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 12.66, Change: +0.10, Percent Change: +0.80

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Apple Expected to Accelerate Growth on Strength of Investment in AI, Tigress Financial Partners Says
Apple Expected to Accelerate Growth on Strength of Investment in AI, Tigress Financial Partners Says
May 30, 2024
09:36 AM EDT, 05/30/2024 (MT Newswires) -- Apple's ( AAPL ) upcoming artificial intelligence-enabled products will drive further acceleration in revenue growth, cash flow and shareholder value gains, Tigress Financial Partners said in a note to clients late Wednesday. The iPhone maker will soon highlight new business applications for its Vision Pro spatial computer. More than 50% of Fortune 100...
FTAI Aviation to Buy Lockheed Martin Commercial Engine Solutions for $170 Million
FTAI Aviation to Buy Lockheed Martin Commercial Engine Solutions for $170 Million
May 30, 2024
09:22 AM EDT, 05/30/2024 (MT Newswires) -- FTAI Aviation ( FTAI ) said Thursday that it has agreed to buy Lockheed Martin Commercial Engine Solutions from Lockheed Martin Canada for $170 million. The deal is slated to be completed in H2. Lockheed Martin Commercial Engine Solutions is an aircraft engine maintenance repair facility in Montreal, Quebec, and FTAI Aviation (...
Foot Locker's Slight Q1 Beat, Guidance Reiteration Seem to Have Satisfied Investors, Wedbush Says; Shares Rise Pre-Bell
Foot Locker's Slight Q1 Beat, Guidance Reiteration Seem to Have Satisfied Investors, Wedbush Says; Shares Rise Pre-Bell
May 30, 2024
09:22 AM EDT, 05/30/2024 (MT Newswires) -- Foot Locker ( FL ) appears to have satisfied investors after reporting fiscal Q1 results that slightly beat analyst estimates and reiterating its fiscal 2024 guidance, Wedbush Securities said Thursday. On Thursday, the company reported fiscal Q1 adjusted EPS of $0.22, down from $0.70 a year earlier. Analysts polled by Capital IQ expected...
Day One Biopharmaceuticals Sells Priority Review Voucher for $108 Million
Day One Biopharmaceuticals Sells Priority Review Voucher for $108 Million
May 30, 2024
09:33 AM EDT, 05/30/2024 (MT Newswires) -- Day One Biopharmaceuticals ( DAWN ) said Thursday it sold its priority review voucher for $108 million to an undisclosed buyer. The company said it was awarded the voucher after the US Food and Drug Administration's accelerated approval of Ojemda, or tovorafenib. As part of the deal, $8.1 million of the amount received...
Copyright 2023-2026 - www.financetom.com All Rights Reserved